The International Society for Fibrinolysis and Proteolysis (ISFP) has selected Brighton for its 21st congress. I am pleased to announce that we have succeeded in developing an attractive scientific program covering a wide range of contemporary topics. I wish to emphasize our intention to devote a substantial part of the 2012 programme to clinical topics, making it a truly multidisciplinary event of interest to clinicians and non-clinicians alike.